Condition
Bispecific Antibodies clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Bispecific Antibodies clinical trials that are recruiting, at sites in 2 countries (most in Italy (1), Germany (1)). 1 was first registered in the last 30 days. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1New in 30 days
- 2Countries
All recruiting trials (2)
-
CAR-T Therapy Safety, Response, and Immune-Escape: Observational Study in Adults
This observational study looks at adults who receive CAR-T cell therapy or bispecific antibodies to see which factors predict response and immune-related side effects.
-
Beta-hydroxybutyrate to boost immunotherapy in multiple myeloma
This study will test whether raising blood beta-hydroxybutyrate with a ketogenic diet or oral ketone supplements can safely improve responses to CAR‑T or BCMA‑directed bispecific therapy in adults with multiple myeloma.
Related topics
Quick answers
How many Bispecific Antibodies clinical trials are recruiting right now?
2, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Italy (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.